As shown above, soluble PD-L1 is strongly associated with progressive disease and tumor burden, both in CRC [13,17,49,50,52] and in other malignant diseases [12,14,15,16,37,38,41,42,43,44,45,46]. This evidence concerns the gene CD274 and neoplasm.